US FDA Office Of New Drugs Likely To Be Headed By Deputy Director Stein

 
• By Kate Rawson
  
The New OND structure and leadership is coming into focus.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership